Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 170
Selected: 0
NCT IDTitle
NCT02382419Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
NCT00634634Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
NCT00728845Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer
NCT00853125Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
NCT00176462CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
NCT04839588Telerehabilitation Cognitive Impairments Following Chemotherapy Usability Study
NCT00156299Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate
NCT04179227Focus Group in Collecting Feedbacks From Indoor Tanning Bed Users for Social Media-Delivered Intervention Development
NCT00161213Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer
NCT03725449Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
NCT03257163Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer
NCT02748564Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
NCT00667901Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT00176501Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
NCT01510119Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
NCT01951534Decisional Aid Intervention for Women Considering Breast Reconstruction
NCT02699996Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors
NCT00176488Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
NCT02526511Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors
NCT03428802Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
NCT00161187Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
NCT02144675Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
NCT01018836Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
NCT05785780Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NCT02421575Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance
NCT00003365Sulindac and Plant Compounds in Preventing Colon Cancer
NCT02203604High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
NCT02015104Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG
NCT00962845Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT02688517Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT017514513-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
NCT03575793A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
NCT01006369Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT00770419Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
NCT02315196Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
NCT03229278Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
NCT04146038Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
NCT04294264TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
NCT03382158International PPB/DICER1 Registry
NCT00496366Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer
NCT00251186First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
NCT00582829Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
NCT06518837Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT00776594Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
NCT00900120Collecting and Storing Blood Samples From Patients With Cancer
NCT02688192Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors
NCT05483491KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
NCT04972019Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study
NCT01828476Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer
NCT02295540Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity